Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1987 1
1989 1
1994 1
1996 1
1997 1
1998 1
2000 1
2003 2
2005 3
2006 7
2007 8
2008 4
2009 8
2010 18
2011 12
2012 32
2013 52
2014 37
2015 22
2016 19
2017 19
2018 23
2019 25
2020 13
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 22516576

272 results
Results by year
Filters applied: . Clear all
Page 1
A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
Walsh PR, Johnson S. Walsh PR, et al. Pediatr Nephrol. 2019 Sep;34(9):1485-1492. doi: 10.1007/s00467-018-4025-0. Epub 2018 Jul 30. Pediatr Nephrol. 2019. PMID: 30058046 Free PMC article. Review.
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM, Brophy PD. Nester CM, et al. Curr Opin Pediatr. 2013 Apr;25(2):225-31. doi: 10.1097/MOP.0b013e32835df4a3. Curr Opin Pediatr. 2013. PMID: 23486421 Review.
Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
Fakhouri F, Frémeaux-Bacchi V, Loirat C. Fakhouri F, et al. Eur J Intern Med. 2013 Sep;24(6):492-5. doi: 10.1016/j.ejim.2013.05.008. Epub 2013 Jun 5. Eur J Intern Med. 2013. PMID: 23756030 Review.
Posttransplant recurrence of atypical hemolytic uremic syndrome.
Valoti E, Alberti M, Noris M. Valoti E, et al. J Nephrol. 2012 Nov-Dec;25(6):911-7. doi: 10.5301/jn.5000146. J Nephrol. 2012. PMID: 22760880 Review.
New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J. Köse O, et al. Semin Thromb Hemost. 2010 Sep;36(6):669-72. doi: 10.1055/s-0030-1262889. Epub 2010 Sep 23. Semin Thromb Hemost. 2010. PMID: 20865644
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M. Alberti M, et al. Am J Transplant. 2013 Aug;13(8):2201-6. doi: 10.1111/ajt.12297. Epub 2013 Jun 3. Am J Transplant. 2013. PMID: 23731345 Free article.
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD. Fox LC, et al. Nephrology (Carlton). 2018 Jun;23(6):507-517. doi: 10.1111/nep.13234. Nephrology (Carlton). 2018. PMID: 29419916 Review.
Atypical hemolytic uremic syndrome.
Loirat C, Frémeaux-Bacchi V. Loirat C, et al. Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Orphanet J Rare Dis. 2011. PMID: 21902819 Free PMC article. Review.
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.
272 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback